Skip to main content

Illuminate your CMS Medicare quality program with an analytics-first strategy

Healthcare providers face difficult choices that can pit their number one priority ─ care quality ─ against the need to reduce costs and increase efficiency. Healthcare providers can achieve all of these goals using data analytics.

An analytics-first strategy enables hospitals, health systems and state hospital associations to make data-informed decisions, not best guesses. This proactive approach can illuminate trends and provide real-time insights that are often hidden or seen too late to change outcomes.
Data from your Medicare quality programs tell a compelling story, 24 hours a day, 365 days a year. DataGen uses Medicare impact modeling, expert analysis and visualizations to reveal data-informed narratives about your performance on three CMS programs:

  • Value-Based Purchasing (VBP);
  • Readmission Reduction Program (RRP); and
  • Hospital-Acquired Conditions (HAC) Reduction Program.

Do you know your organization’s stories?

The biggest and best tool in your healthcare management toolkit: Data

DataGen data analytics can help you:

  • reduce the negative, avoidable impacts of CMS penalties;
  • ensure more revenue flows to your organization; and
  • forewarn of regulatory impacts that make the difference between positive or negative outcomes for patients, providers and your community.

The DataGen Medicare FFS Quality Suite helps you identify improvement strategies by drawing out projected quality program impacts and performance trends, and enabling deep comparisons.

DataGen can help you monitor your hospital’s national peer percentile rank, foretell future-state revenue and gain more under Medicare quality programs.

Who wouldn’t want to stay ahead of that?

Take a peek at the data insights you may be missing

Each year, CMS adjusts payments for the acute care inpatient hospital setting based on performance in the VBP, RRP and HAC programs. DataGen’s most recent analysis compared these impacts for federal fiscal years 2021 to 2023.*

For RRP in FFY 2023, DataGen estimated a total loss across the country of $320 million due to poor performance on readmission quality measures. The map below shows state-by-state percentage impacts.

FFY 2023 RRP Percent Impact on Base Operating Dollars

*Note: CMS is neither penalizing nor rewarding hospitals for FFYs 2022 and 2023 for VBP due to the COVID-19 pandemic. For the same reason, CMS is not penalizing hospitals for the FFY 2023 HAC program.

Customized data stories at your fingertips

DataGen Medicare FFS Quality Suite enables you to select filters that narrow (e.g., specific facility) or broaden (e.g., market, region, state or nation) your data. Report toggles can instantly shift the data story. Other filters — for example, potential Medicare cuts, condition revenue and estimated impacts — create user-selected granularity and add customized storytelling to reporting.

DataGen’s visualization platform also contains dozens of native reports, so your stories can be interesting and insightful from the start.

Data stories from current CMS headlines

DataGen pools data and insight comparisons from multiple sources, including regulatory, legislative, quality, financial and operations. This allows you to identify and address impacts quickly to improve patient outcomes.

Find out how an analytics-first approach can strengthen your organization’s healthcare management. Reach out to DataGen today.


Popular posts from this blog

Alternative payment models: Strategies for success

In this edition of DataGen Insights, we look at how alternative payment model participants can ensure their processes and workflows are optimally set up for success. To help, DataGen listed the top three strategies all providers participating in APMs can employ and created a handy checklist to enable maximum returns and reduce financial risk. Please explore our website to learn more about our  products and services .  Download DataGen Insights today .  We hope you enjoy!

CMMI’s New Enhancing Oncology Model – Deadline Approaching

As the final at-risk period for the Oncology Care Model was closing at the end of June, the Center for Medicare and Medicaid Innovation announced its new Enhancing Oncology Model (EOM). EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment.  What is EOM? EOM is a voluntary, five-year model set to begin July 1, 2023. Patients undergoing chemotherapy for the treatment of cancer will trigger six-month episodes of care.  Eligible EOM participants include physician group practices with at least one Medicare-enrolled physician or a non-physician practitioner who furnishes evaluation and management services to Medicare beneficiaries receiving chemotherapy for cancer treatment.  EOM participants are required to implement eight participant redesign activities to drive care transformation in their practice. Examples include the provision of patient navigation, 24/7 access to an appropriate c

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit